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The product of the Escherichia coli F plasmid traI
gene is required for DNA transfer via bacterial conjuga-
tion. This bifunctional protein catalyzes the unwinding
of duplex DNA and is a sequence-specific DNA transes-
terase. The latter activity provides the site- and strand-
specific nick required to initiate DNA transfer. To ad-
dress the role of the TraI helicase activity in conjugative
DNA transfer traI mutants were constructed and their
function in DNA transfer was evaluated using genetic
and biochemical methods. A traI deletion/insertion mu-
tant was transfer-defective as expected. A traI C-termi-
nal deletion that removed the helicase-associated motifs
was also transfer-defective despite the fact that the re-
gion of traI encoding the transesterase activity was in-
tact. Biochemical studies demonstrated that the N-ter-
minal domain was sufficient to catalyze oriT-dependent
transesterase activity. Thus, a functional transesterase
was not sufficient to support DNA transfer. Finally, a
point mutant, TraI-K998M, that lacked detectable heli-
case activity was characterized. This protein catalyzed
oriT-dependent transesterase activity in vitro and in
vivo but failed to complement a traI deletion strain in
conjugative DNA transfer assays. Thus, both the trans-
esterase and helicase activities of TraI are essential for
DNA strand transfer.
Conjugative DNA transfer (CDT)1 provides an important
means for the horizontal transfer of genetic traits among bac-
terial populations as well as the transphylic transfer of genes
from Agrobacterium tumifaciens to plants. The latter process
occurs by essentially the same mechanism. CDT has been ex-
tensively studied in a variety of conjugative plasmids and
transposons, and details surrounding the biochemistry and
regulation of this process are emerging (for reviews see Refs.
1–4). Conjugation begins with the formation of a stable mating
pair between a donor cell and a recipient cell. In response to a
“mating signal” that remains to be defined, DNA strand trans-
fer is initiated from a site- and strand-specific nick within the
plasmid oriT (origin of transfer). A single strand of DNA is then
passed into the recipient cell with an overall 59 to 39 polarity
and is stabilized in the recipient by one of two mechanisms (i)
circularization and second strand synthesis or (ii) recombina-
tion into the recipient genome.
Molecular details surrounding the initiation of strand trans-
fer are coming to light in several systems including the Esch-
erichia coli F plasmid. In the F plasmid system a specific
nucleoprotein complex, so far known to consist of the F-encoded
proteins TraY and TraI and the host encoded integration host
factor (5, 6), is required to initiate the physical transfer of
single-stranded DNA (ssDNA). These components have been
shown to be indispensable for transfer in vivo (7–13) and are
sufficient to promote formation of a TraI-catalyzed site- and
strand-specific nick on the transferred strand in vitro (5). The
192-kDa product of the F plasmid traI gene, known as DNA
helicase I or TraI (14), catalyzes a site- and strand-specific
transesterase reaction (15–17) and a helicase reaction (18–20).
TraY and integration host factor are both site-specific DNA-
binding proteins (21, 22) that bind oriT and apparently act to
impose a particular architecture on that region of the plasmid
to facilitate the binding of TraI and formation of the active
initiation complex.
TraI is a key player in the initiation of CDT, and two distinct
biochemical activities intrinsic to TraI are believed to be rele-
vant to its biological role. One, a DNA transesterase activity, is
characterized by the ability of the protein to introduce a se-
quence- and strand-specific nick at the F plasmid oriT (15, 16,
23, 24). The scissile phosphodiester bond is referred to as nic.
The reaction involves a reversible transesterification between
the 59 phosphate of a guanosyl residue on the 39 side of nic
(G140) (2), and a tyrosine near the N-terminal end of the pro-
tein.2 TraI is also a nucleoside 59-triphosphate hydrolysis-de-
pendent 59 to 39 DNA helicase (18–20). The helicase-associated
motifs of TraI are clustered in the C-terminal region of the
protein. Both regions of TraI have similarities in their primary
structure to other transesterases and helicases (2, 25–30).
The transesterase activity makes TraI indispensable for
DNA transfer because formation of the sequence- and strand-
specific nick is a required first step in strand transfer and is a
plasmid-specific function. Interestingly, the overwhelming ma-
jority of CDT initiator transesterases do not contain identifia-
ble helicase motifs nor do they exhibit helicase activity (for
review see Ref. 24). However, TraI is believed to use its helicase
activity to catalyze F plasmid unwinding concomitant with
DNA transfer, thus providing the force required to drive a
single strand of DNA from the donor to the recipient bacterium
(14). This notion is based on the following lines of reasoning: (i)
to transfer only one strand of the duplex plasmid unwinding is
a mechanistic requirement, (ii) TraI physically interacts with
the transferred (T)-strand and is required for transfer, and (iii)
the 59 to 39 polarity of the TraI helicase activity is consistent
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with the observed polarity of strand transfer (31, 32). In plas-
mid systems harboring a CDT initiator transesterase without
helicase activity, this role is presumably filled via the recruit-
ment of either a host- or plasmid-encoded helicase. Alterna-
tively, strand displacement synthesis catalyzed by a DNA po-
lymerase concomitant with DNA transfer could provide the
ssDNA that is transferred to the recipient. Thus, there is nei-
ther precedent nor direct evidence demonstrating a require-
ment for the helicase activity of TraI in CDT.
To investigate the role of the TraI helicase activity in CDT,
we made several traI mutants and evaluated their function in
DNA transfer using genetic and biochemical methods. A traI
deletion/insertion strain was transfer-defective as expected. A
traI C-terminal deletion that removed the helicase-associated
motifs was also transfer-defective despite the fact that the
region of traI encoding the transesterase activity was intact.
Biochemical studies demonstrated that the N-terminal 954
residues of TraI were sufficient to catalyze oriT-dependent
transesterase activity in vitro, comparable with that of native
TraI. Thus, a functional transesterase was not sufficient to
support CDT. Finally, a point mutant, TraI-K998M, that
lacked detectable helicase activity and had only minimal DNA-
dependent ATPase activity was characterized. This protein
catalyzed oriT-dependent transesterase activity in vitro and in
vivo but failed to complement a traI deletion strain in conjuga-
tive DNA transfer assays.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Nucleic Acids—E. coli strains and plasmids
used in this study are listed in Table I. DNA oligonucleotides are listed
in Table II. Gene disruptions were constructed in JC7623 as described
(33) and moved to other strains by transformation. Overexpression of
the traI alleles cloned into pET11d (Novagen, Madison, WI) was in
HMS174(DE3). Donor strains for mating experiments were constructed
by transforming HMS174(DE3) with the appropriate pOX38T deriva-
tive and, where indicated, the appropriate pET11d-traI allele. Either
JS4 or HB101 served as the recipient strain in all cases. Nucleic acids
were quantified by spectroscopy at 260 nm.
Standard Genetic Techniques—Bacteria were grown in 2XYT or LB
(34). LB was supplemented with 1.5% agar for plates. Medium was
supplemented with antibiotics, as appropriate, at the following concen-
trations: ampicillin, 100 mg/ml; tetracycline, 12 mg/ml; streptomycin, 30
mg/ml; kanamycin, 30 mg/ml; and chloramphenicol, 20 mg/ml. The liquid
mating assay protocol was as follows. Donor and recipient strains were
diluted 1:50 into LB from saturated overnight cultures grown under
selection and allowed to grow to mid or late log phase in the absence of
selection at 37 °C. Donors and recipients were then mixed at a volume
ratio of one donor to nine recipients and incubated at 37 °C. After 5 min,
the mating mixtures were diluted 1:10 into LB and incubated at 37 °C
for an additional 30 min. The mating mixtures were then vigorously
vortexed to disrupt mating pairs and 10-fold serial dilutions were pre-
pared at room temperature in phosphate buffered saline. Appropriate
dilutions were plated onto LB agar containing streptomycin and tetra-
cycline to counter-select donors and unmated recipients while selecting
for transconjugants. Aliquots of the unmated donor and recipient cul-
tures were subjected to 10-fold serial dilution into phosphate buffered
saline and plated onto LB agar containing the appropriate antibiotics to
determine the viable donor cell count and the viable recipient cell count.
Mating frequency was calculated as the number of transconjugants/100
viable donor cells.
Plasmid Constructions—The traI gene was amplified in a polymer-
ase chain reaction (PCR) with Vent DNA polymerase using primers 049
and 050 (gift of Dr. Michael T. Howard, University of Utah) and pMP8
(35) as the template. The primers contain BamHI sites that were used
to clone the PCR product into the unique BamHI site of the Litmus28
phagemid (New England Biolabs, Beverly, MA). This plasmid was des-
ignated L28traI. The traI gene was sequenced to ensure the absence of
PCR-generated mutations.
L28traI was modified to replace a portion of the traI gene with a
kanamycin resistance gene. The central portion of the traI coding region
was removed by digestion with SphI and BsrGI, and the remainder of
the plasmid (having 496 bp of 59 and 938 bp of 39 traI sequence) was gel
purified. The kanamycin resistance gene (kanR) from pACYC177 was
cloned into a hybrid polylinker derived from pLit28 and pLit38. This
allowed for the generation of a DNA fragment containing kanR and
having overhangs compatible with SphI and BsrGI. The appropriate
DNA fragment was gel purified and ligated to the traI remnant to
produce a plasmid in which the direction of transcription of the kanR
gene was the same as that of traI. A representative clone was selected
on LB plates containing kanamycin, characterized by restriction map-
ping, and designated ptraIK.
The ptraIK construct was used to disrupt the traI locus on the F
derivative pOX38T (the “T” denotes tetracycline resistance) (gift of Dr.
Elisebeth Raleigh, New England Biolabs) by the following procedure.
First, pOX38T was introduced into JC7623 by transformation. Several
colonies were selected and screened for a transfer proficient phenotype,
and a representative isolate was designated DB4 (Table I). A BamHI
fragment of ptraIK containing the disrupted traI gene was transformed
TABLE I
Bacterial strains and plasmids
Strain designation Significant feature(s) Source or reference
Cell strains
HB101 leuB6, D(gpt-proA)62, lacY1, supE44, galK2, recA13, rpsL20, xyl-5,
mtl-1, D(mcrC-mrr), ara-14
Ref. 46
JC7623 thr-1, ara-14, leuB6, DE(gpt-proA)62, lacY1, sbcC201, tsx-33, gsr-0,
glnV44(AS), galK2, LAM-, rac-0, sbcB15, hisG4(Oc), rfbD1,
recB21, recC22, rpsL31, kdgK51, xylA5, mtl-1, argE3(Oc), thi-1
Ref. 47
JC7623 derivatives
DB4 pOX38T This work
DB5 pOX38TDtraI<kan This work
DB6 pOX38TtraIDC This work
HMS174(lDE3) F2 recA1 hsdR (rK12
2mK12
1) RifR (DE3) Novagen
HMS174(lDE3) derivatives
DB10 pOX38T This work
DB11 pOX38TDtraI<kan This work
DB20 pOX38TtraIDC This work
Plasmids
pOX38T Transfer F 1derivative Ref. 39
pOX38TDtraI<kan Transfer F 2derivative This work
pOX38TtraIDC F derivative with the C-terminal end of traI gene deleted This work
Litmus 28 Cloning vector New England Biolabs
pET11d Expression vector Novagen
pBSoriT Bluescript plasmid with F oriT Ref. 15
pBS Bluescript plasmid lacking F oriT Ref. 15
pACYCoriT pLysE derivative with F oriT This work
pET11d-traI Expression vector with traI gene This work
pET11d-traIN956 Expression vector with C-terminal deletion of traI gene This work
pET11d-traIK998M Expression vector with traI point mutant This work
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into DB4. Transformants harboring the disrupted traI gene were se-
lected on LB agar containing kanamycin and tetracycline. Deletion/
insertion at the traI locus was confirmed by restriction mapping and
Southern blot analysis of the pOX38T derivative (data not shown). The
new pOX38T derivative was designated pOX38TDtraI::kan, and the
JC7623 derivative strain that harbored it was designated DB5.
The intact traI gene was initially subcloned from L28traI into
pET11d using the BamHI sites resident on each plasmid. This resulted
in two ribosome binding sites upstream of traI, one site from pET11d
and the native traI ribosome binding site. The pET11d ribosome bind-
ing site was deleted using the flanking XbaI and NheI sites. This
construct was designated pET11d-traI.
A unique KpnI/Acc651 site was introduced into the traI gene in
pET11d-traI at codon 955. This was done by PCR with Vent DNA
polymerase using pMP8 as the template, primers 049 and 054 to am-
plify the first 2865 bp of the gene, and primers 050 and 055 to amplify
the last 2406 bp of the gene. The two PCR products were digested with
KpnI and ligated. As expected, ligation resulted in three products: a
5730-bp product and a 4812-bp product that were head to head ligations
of the 59 and 39 halves of the gene, respectively, and the desired 5271-bp
product. The latter was gel purified, digested with BamHI, and cloned
into the unique BamHI site of pET11d. The KpnI/Acc651 site was used
to create a C-terminal deletion of the TraI protein. The construct de-
scribed above was digested with Acc651 and BsrGI, which leaves 2865
bp of 59 and 938 bp of 39 traI sequence. The ligation of these compatible
cohesive ends brings a TAA stop codon into frame two codons after
codon 955 and, therefore, eliminates expression of the C-terminal re-
gion (residues 955–1756), which includes the helicase-associated mo-
tifs. This construct was designated pET11d-traIN956.
To make the pOX38TtraIDC deletion, the Acc651 and BsrGI sites in
L28traI were used to replace most of the traI C-terminal coding region,
including the entire region encoding the helicase-associated motifs,
with a kanamycin resistance marker. This plasmid was designated
L28traIDCK. The disrupted traI gene in L28traIDCK was amplified
with primers 049 and 050 and transformed into DB4. The traIDC
disruption in pOX38T was assessed in the same manner as outlined
above for pOX38TDtraI. The plasmid was designated pOX38TtraIDC,
and the resulting derivative strain was designated DB6. pOX38T,
pOX38TDtraI, and pOX38TtraIDC were introduced into HMS174(DE3)
by transformation and the resulting strains were designated DB10,
DB11, and DB20, respectively (Table I).
The plasmid pBSoriT was described previously (15). pACYCoriT is a
derivative of pLysE (Novagen) containing the F plasmid oriT region. It
was constructed by cloning the 932-bp PvuII fragment from pBSoriT
into pLysE cleaved with EcoRV. The construction was confirmed by
restriction digest analysis.
pET11d-traIK998M is a derivative of pET11d-traI with a point mu-
tation at codon 998 that changes the conserved lysine in helicase motif
I to methionine. This mutation was made by PCR using primers K998M
and K998WT (Table II) as described previously (36). The traI-K998M
gene was sequenced to confirm the K998M mutation and to ensure the
absence of other mutations.
TraIN956 Purification—One liter of HMS174(DE3) harboring
pET11d-traIN956 was grown to an A600 of 0.7, and isopropyl-thio-B-D-
galactopyranoside was added to a final concentration of 0.5 mM to
induce protein expression. Following a 3-h incubation at 37 °C, ;8 g of
cells were recovered by centrifugation and stored at 280 °C. The cell
paste was suspended in 32 ml of cold lysis buffer (40 mM Tris-HCl, pH
8.3, 7.5% sucrose, 150 mM NaCl, 4 mM EDTA, 5 mM b-mercaptoethanol,
10 mM phenylmethane-sulfonyl fluoride). Lysozyme was added to 0.3
mg/ml, Brij-35 was added to 0.4%, and the preparation was stirred at
4 °C for 1 h. The lysate was sonicated to reduce viscosity and centri-
fuged for 60 min at 27,000 3 g. Solid ammonium sulfate was added to
the clarified supernatant to 60% saturation, and the resulting precipi-
tate was recovered by centrifugation for 60 min at 27,000 3 g. The pellet
was suspended in 5 ml of Buffer B (50 mM Tris-HCl, pH 7.5, 1 mM
EDTA, 5 mM dithiothreitol, 20% glycerol) and dialyzed against 200
volumes of Buffer B containing 200 mM NaCl. This was designated
Fraction II.
Fraction II was applied to a 10-ml heparin-agarose (Sigma) column
(cross-sectional area, 0.79 cm2) equilibrated in Buffer B 1 0.2 M NaCl,
and the column was washed to baseline as judged by Bradford protein
assay. A 10 column volume NaCl gradient from 0.2 to 0.8 M in Buffer B
was used to develop the column. The elution of TraIN956 was followed
by Western blot using antibodies raised against purified TraI. The
protein eluted between 0.37 and 0.44 M NaCl. Peak fractions were
pooled and designated Fraction III. Fraction III was assayed for oriT-
dependent transesterase activity as described below. In addition to a
pronounced oriT-specific transesterase activity, a second activity con-
sistent with a type II topoisomerase was evident, irrespective of the
presence of oriT. This activity could be mitigated with heat treatment
(70 °C for 5 min) with no apparent reduction in the oriT-specific nicking
activity. The contaminating activity could also be removed by further
purification.
Fraction III was applied to a 10-ml phosphocellulose column (cross-
sectional area, 0.79 cm2). A 10-column volume NaCl gradient from 0.1
to 0.7 M was used to develop the column. TraIN956 eluted over a range
from 0.2 to 0.45 M NaCl. The purity of these fractions was determined
by polyacrylamide gel electrophoresis in the presence of SDS. Faster
migrating species, evident by Coomassie staining, strongly cross-re-
acted with polyclonal antibody raised to TraI, suggesting that they were
derived from proteolysis of the 956-amino acid species. The peak frac-
tions were pooled, quantified by Bradford protein assay, and used to
assess the oriT-specific nicking activity of the N-terminal 956 residues
of TraI.
TraI-K998M Purification—TraI-K998M was purified using TraI pu-
rification procedure described previously (19) with minor modifications.
DNA Helicase Assays—A partial duplex helicase substrate was made
essentially as described (37). Briefly, a 91-base oligonucleotide was
annealed to its complementary sequence on purified M13mp6 ssDNA at
a 1:1 molar ratio. The partial duplex DNA was 39 end-labeled using the
Klenow fragment of E. coli DNA polymerase I and [a-32P]dCTP. After
phenol/chloroform extraction, the substrate was further purified on a
Biogel A5M column. The void volume fractions were pooled, ethanol
precipitated, and suspended in 10 mM Tris-HCl, pH 7.5, 1 mM EDTA to
a final concentration of ;5 fmol/ml.
DNA unwinding reaction mixtures (typically 20 ml) contained 25 mM
Tris-HCl, pH 7.5, 20 mM NaCl, 3 mM MgCl2, 5 mM b-mercaptoethanol,
10 fmol of DNA substrate, and 2 mM ATP. Reaction mixtures were
assembled at room temperature, and the reaction was initiated by the
addition of enzyme. Incubations were at 37 °C for 20 min. The reaction
mixtures were quenched by the addition of EDTA to 25 mM and SDS to
1%. Reaction products were resolved from the substrate on an 8% (20:1
cross-linking) native polyacrylamide gel.
ATPase Assays—Reaction mixtures (20 ml) were identical with those
used for helicase assays with the following exceptions: 15 pmol
[a-32P]ATP was added to each reaction mixture (final concentration of
ATP, 2 mM) that contained 0.75 mg of M13mp6 ssDNA instead of the
partial duplex helicase substrate. Reactions were assembled at room
temperature and initiated by the addition of enzyme. Incubations were
at 37 °C for 10 min. The reactions were quenched by the addition of
EDTA to a final concentration of 85 mM. 4 ml was spotted onto a
cellulose polyethyleneimine thin layer chromatography plate (J. T.
Baker, Phillipsburg, NJ) and allowed to dry, and the plates were devel-
oped with a mobile phase consisting of 1.0 M formic acid and 0.8 M LiCl.
The plates were allowed to dry, and the degree of ATP hydrolysis was
quantified using a PhosphorImager and ImageQuant software (Molec-
ular Dynamics).
Duplex DNA Relaxation Assays—Assays were done in a manner
slightly modified from those described previously (15). In addition to the
protein (usually present at 50–60 nM), a typical reaction mixture (20 ml)
contained 6 nM pBSoriT DNA (either supercoiled or covalently closed
TABLE II
DNA oligonucleotides
Name Sequence (59 to 39) Description
db049 CGGAATTCGGATCCGTCAAAGGGATATACGTTTA 59 PCR primer for traI gene
db050 CGAAGCTTGGATCCTATCAGTCTCCACCCAGGGT 39 PCR primer for amplifying traI gene
db054 GCGGGTACCACCGCCTCCTTACCTTCGAGAATATGGC Changes codon 955 from ATG (M) to GTA (V)
db055 GCGGGTACCGCTGATGGAGAGAGTACCTGGCG Changes codon 955 from ATG (M) to GTA (V)
K998M TGACCACACAGTTCAGGCCTGTGATGT Changes codon 998 from AAG (K) to ATG (M)
K998WT ACCCACACCGGCATAGCCCTGTAC Mutagenesis primer for amplifying traI gene
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circular), 40 mM Tris-HCl, pH 7.5, 6 mM MgCl2, and 15% glycerol.
Reactions were assembled at room temperature and incubated at 37 °C
for 20 min. Reactions were stopped by the addition of Proteinase K
(Roche Molecular Biochemicals) and SDS to final concentrations of 1
mg/ml and 0.25%, respectively, and allowed to incubate at 37 °C for an
additional 20 min. The products were resolved on 0.8% agarose gels in
the absence (in the case of sc-pBSoriT), or presence (in the case of
ccc-pBSoriT) of ethidium bromide, followed by staining and/or destain-
ing, as required to visualize the results. For quantification of the trans-
esterase reaction catalyzed by TraI and TraI-K998M, pBSoriT was
digested with XbaI to linearize the plasmid, and known amounts of
plasmid DNA were loaded on the agarose gel to produce a standard
curve. The fluorescence of the nicked DNA species was compared with
the fluorescence of the standard curve to determine the amount of DNA
that was nicked using an Eagle Eye imaging system (Stratagene, La
Jolla, CA).
DNA Oligonucleotide Cleavage/Exchange Assays—Reaction condi-
tions were the same as for the duplex DNA relaxation assays except the
substrates were ssDNA oligonucleotides either 22 or 30 nucleotides in
length containing the nic site in F oriT. Cleavage assays typically
contained 0.5 pmol of one or the other 59 end-labeled substrate mole-
cule. The exchange reaction contained 0.5 pmol of 32P-labeled 30-mer,
and 5.0 pmol of unlabeled 22-mer. The reactions were assembled at
room temperature, initiated by the addition of enzyme, and incubated
at 37 °C for 30 min. They were stopped by the addition of 0.25 volumes
of a solution containing 95% formamide, 20 mM EDTA, 0.05% bromphe-
nol blue, and 0.05% xylene cyanol. The reactions were placed in a
boiling water bath for 2–3 min and then loaded onto a 16% denaturing
polyacrylamide gel (20:1 cross-linking ratio). Electrophoresis was at a
constant power of 50 watts until the xylene cyanol dye was at the
midpoint of the gel. The gels were visualized using either x-ray film
autoradiography or a PhosphorImager.
In Vivo Nicking Assays—Cell lysates were prepared and analyzed as
described previously (38). The agarose gels were transferred to a nitro-
cellulose membrane by Southern blot (36). A 535-bp SalI-SpeI fragment
of pACYCoriT was 39 end-labeled using the Klenow fragment of E. coli
DNA polymerase I and [a-32P]dCTP. The preparation was phenol/chlo-
roform extracted and further purified on a Biogel A5M column. The void
volume fractions were pooled, ethanol precipitated, and suspended in
10 mM Tris-HCl, pH 7.5, 1 mM EDTA. This was used to probe the blot
to detect and quantify supercoiled and nicked DNA species.
RESULTS
Purified TraI protein catalyzes two distinct biochemical re-
actions, a site- and strand-specific transesterase reaction, and
a 59 to 39 helicase reaction (15–20). The transesterase provides
the site- and strand-specific nick required to initiate DNA
strand transfer and is, therefore, required for DNA strand
transfer. The helicase is believed to unwind the duplex plasmid
and thereby provide the force required to transfer ssDNA from
the donor to the recipient (14). However, direct evidence to
indicate that the helicase activity of TraI is required for DNA
strand transfer is lacking. Moreover, other transesterases
(with very few exceptions) that initiate CDT do not catalyze a
helicase reaction. To determine whether the helicase activity of
TraI is required for its function in DNA transfer, we made
several traI mutants and tested each mutant for function using
in vivo and in vitro assays.
The role of the traI gene product in CDT was evaluated using
the self-transmissible F plasmid derivative pOX38T (39). This
mini-F plasmid encodes all the proteins required to sponsor its
own conjugative transfer as well as a gene encoding resistance
to tetracycline to aid in selecting cells that have received the
plasmid by CDT. The plasmid was introduced into E. coli
HMS174(DE3) by transformation to construct the donor DB10
(Table I). This donor strain transferred pOX38T at high fre-
quency to a recipient strain in standard liquid mating experi-
ments (Table III). Because the recipient strain inherits the
transmissible plasmid, it immediately becomes a “donor” strain
and can transfer the plasmid to another recipient lacking the
plasmid. In this way the self-transmissible pOX38T can be
rapidly transferred to all the cells in a bacterial population.
A central region of the traI gene on pOX38T was deleted and
replaced with a gene encoding kanamycin resistance as de-
scribed under “Experimental Procedures” to construct
pOX38TDtraI. This deletion/insertion was constructed using
convenient restriction sites and was designed to eliminate ex-
pression of an active protein. Western blots failed to detect the
expression of protein that reacted with anti-TraI antibodies
(data not shown). This plasmid was introduced into E. coli
HMS174(DE3) by transformation to construct the isogenic do-
nor DB11 (Table I). The pOX38TDtraI plasmid cannot sponsor
its own transfer to a recipient strain (Table III), as expected,
because it lacks the essential traI gene, which is known to be
required for DNA transfer (7). In all experiments we failed to
detect even a single transconjugant and, therefore, transfer
frequency was estimated to be less than the limit of detection in
the mating assay. It should be noted that the actual transfer
frequency is likely to be much lower.
DNA transfer was restored to this strain by providing TraI
protein from a second plasmid, pET11d-traI, that expressed the
traI gene (Table III). Transfer frequency in the complemented
donor DB11 was consistently lower than transfer frequency in
the donor DB10. This is due to the fact that pOX38T is compe-
tent to sequentially mobilize itself throughout a bacterial pop-
ulation as explained above, whereas pOX38TDtraI can only
transfer out of the donor strain and into the first recipient
because the recipient does not contain the complementing plas-
mid. Therefore, it is not surprising that DB10 transfers
pOX38T at somewhat higher frequencies than DB11 contain-
ing a complementing plasmid.
To evaluate the role of the TraI helicase domain in CDT, a
second derivative of pOX38T, pOX38TtraIDC, lacking the C-
terminal end of traI was constructed. All the helicase-associ-
ated motifs were removed in this deletion, whereas the trans-
esterase domain was left intact. The deletion plasmid was
introduced into E. coli HMS174(DE3) to construct the isogenic
donor strain DB20 (Table I). As observed with the plasmid
lacking the traI gene, this plasmid was also unable to support
its own transfer to a recipient bacterium (Table III). This result
suggests that the presence of the N-terminal transesterase
domain is not sufficient to support CDT. Providing full-length
TraI from a second plasmid restored the loss of strand transfer
in DB20 (data not shown).
The genetic data shown above indicate that the presence of
the N-terminal transesterase, in the absence of the helicase, is
not sufficient for F plasmid-mediated CDT. To demonstrate
that the N-terminal end of TraI was competent to catalyze the
appropriate transesterase reaction in the absence of the heli-
case-associated motifs, the C-terminal end of the traI gene was
deleted from pET11d-traI to produce pET11d-traIN956, which
expressed the N-terminal portion of TraI. This protein is anal-
ogous to the TraI produced from pOX38TtraIDC in the donor
strain DB20. TraIN956 was purified as described under “Ex-
TABLE III
Transfer complementation
Liquid mating assays were performed as described under “Experi-
mental Procedures.” The data represent the average and standard
deviation about the mean of at least three independent experiments.
The values reported as , x represent the sensitivity of the experiment.
In each case no transconjugants were obtained, and, therefore, the
transfer frequency is likely to be much lower than the value reported.
Strain Relevant genotype Transfer frequency
transconjugants/100 donors
DB10 pOX38T 7.05 6 0.5
DB11 pOX38TDtraI ,8 3 1026
pOX38TDtraI/pET11d-traI 1.41 6 0.27
pOX38TDtraI/pET11d-traIN956 ,8 3 1026
pOX38TDtraI/pET11d-traIK998M ,7 3 1024
DB20 pOX38TtraIDC ,8 3 1026
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perimental Procedures,” and its biochemical activities were
measured in vitro. TraIN956 exhibited no detectable helicase
activity (data not shown), as expected, because all the helicase-
associated motifs were deleted. However, TraIN956 was able to
catalyze an oriT-dependent transesterase reaction (Fig. 1). In
these assays, the ability of the protein to catalyze transesteri-
fication at the F plasmid oriT was measured by assessing
conversion of a supercoiled plasmid containing oriT to a nicked
species (15, 16). Both TraI and TraIN956 catalyzed a transes-
terification reaction (Fig. 1, A, lanes 3 and 5, and B, lanes 7 and
10). Previous studies (15) have shown that this reaction re-
quires a negatively supercoiled DNA substrate; relaxed co-
valently closed circular DNA will not serve as a substrate. This
was also true for TraIN956 (Fig. 1A, lanes 4 and 6).
The specificity of the transesterase reaction, its dependence
on MgCl2, and its inhibition by NaCl are demonstrated in Fig.
1B. Both TraI and TraIN956 failed to catalyze relaxation of a
plasmid lacking the F plasmid oriT (Fig. 1B, lanes 1–3). The
slight increase in open circular form DNA observed in lane 3 is
due to a minor topoisomerase contaminant (see “Experimental
Procedures”). The presence of intermediate species between the
supercoiled and open circular bands in lane 3 is consistent with
this interpretation. The transesterification reaction required
MgCl2 (Fig. 1B, lanes 7 and 10) and was inhibited by 150 mM
NaCl (Fig. 1B, lanes 8 and 11) as previously reported (5). Thus,
at this level of analysis, the transesterase reaction catalyzed by
TraIN956 compared favorably with that catalyzed by the wild-
type TraI.
Several site-specific DNA transesterases also catalyze cleav-
age of a ssDNA oligonucleotide whose sequence is derived from
the cognate binding site of the protein. If a second oligonucleo-
tide encompassing the same sequence, but of different length,
is included in the reaction, then transesterase-catalyzed strand
exchange can be observed (Fig. 2A and Refs. 17 and 40–43).
Cleavage of a 59 end-labeled 30-mer was observed using both
TraI and TraIN956 and was dependent upon the presence of
MgCl2 (Fig. 2B, compare lanes 3 and 4 with lanes 5 and 6).
Strand exchange was observed upon addition of an unlabeled
22-mer to the reactions and was manifested by the generation
of a labeled 28-mer (Fig. 2B, lanes 7 and 8). Both the cleavage
and the exchange reactions catalyzed by TraIN956 were qual-
itatively equivalent to those catalyzed by wild-type TraI.
Therefore, the N-terminal half of TraI protein expressed in the
donor DB20 is a competent transesterase.
To rule out the possibility that TraI protein had a third, still
undiscovered, activity in CDT that was compromised in the
deletion mutant, a plasmid that expressed a TraI point mutant
that eliminated helicase activity but retained transesterase
activity was constructed. The plasmid pET11d-traIK998M ex-
pressed a TraI point mutant containing a lysine to methionine
mutation in the essential lysine (Lys998) in helicase motif I.
FIG. 1. Comparison of the transesterase reaction catalyzed by
TraI and TraIN956. A, TraI and TraIN956 were incubated with neg-
atively supercoiled (sc) pBSoriT DNA (lanes 3 and 5) or relaxed co-
valently closed circular (ccc) pBSoriT DNA (lanes 4 and 6) as described
under “Experimental Procedures.” B, each protein was incubated with
supercoiled DNA (6 oriT as indicated) in the presence (lanes 2, 3, 7, 8,
10, and 11) or absence (lanes 6 and 9) of 6 mM MgCl2. NaCl was added
to the standard reaction to a final concentration of 150 mM (lanes 8 and
11). Reaction products were resolved on a 0.8% agarose gel, and the
results were visualized by staining with ethidium bromide (0.3 mg/ml).
NP, no protein; OC, open circular DNA.
FIG. 2. The cleavage and exchange reactions catalyzed by TraI
and TraIN956. A, a schematic representation of the oligonucleotide
cleavage and exchange reactions, and the predicted products. Asterisks
denote radioactive phosphates located on the 59 end of DNA oligonu-
cleotides. Open and filled rectangles represent 30-mer and 22-mer,
respectively. B, autoradiograph of cleavage and exchange reactions.
The expected reaction products are indicated at the right. Each protein
was incubated with 32P-labeled DNA (30-mer) in the presence (lanes 4
and 6) or absence (lanes 3 and 5) of 6 mM MgCl2. Addition of a 10-fold
molar excess of the unlabeled 22-mer resulted in the generation of novel
59-end-labeled species with a predicted length of 28 bases (lanes 7 and
8). Reactions were as described under “Experimental Procedures.” wt,
wild type.
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This plasmid was introduced into the donor strain DB11 (con-
taining pOX38TDtraI), and DNA transfer was measured. This
cell strain was transfer-deficient, indicating that the TraI point
mutant cannot substitute for TraI (Table III).
To eliminate the unlikely possibility that this mutant protein
lacked transesterase activity, the TraI-K998M mutant protein
was purified to apparent homogeneity to evaluate its biochem-
ical activities. The helicase, ssDNA-dependent ATPase, and
transesterase activities of the mutant protein were measured
and compared with the wild-type protein. The kcat for ATP
hydrolysis was reduced to less than 0.08% that of wild-type
TraI (data not shown) as expected because the lysine residue is
essential for the ATPase reaction catalyzed by helicases (44).
The unwinding activity of TraI-K998M was measured using a
92-bp partial duplex substrate (Fig. 3). No detectable unwind-
ing of this substrate by TraI-K998M was observed even at high
protein concentration (312 nM). Wild-type TraI, by comparison,
unwound nearly all of the partial duplex substrate at a concen-
tration of 8 nM protein (Fig. 3, inset). The transesterase activity
of TraI-K998M was measured using the agarose gel assay
described above. TraI and TraI-K998M both catalyzed the con-
version of supercoiled pBSoriT to an open circular, nicked form
of the DNA (Fig. 4). Control experiments using a plasmid that
lacked the F oriT sequence demonstrated that the reaction was
specific for the F plasmid oriT (Fig. 4, lanes 8–10).
Although not likely, it was possible that TraI-K998M was not
expressed in DB11 because of the presence of the point muta-
tion. To ensure that expression of TraI and TraI-K998M were
at equivalent levels, extracts were prepared from DB11 1
pET11d-traI and DB11 1 pED11d-TraI-K998M, and the level
of TraI expression was determined by Western blot using an-
tiserum directed against TraI. Both proteins were expressed in
the donor strain at equivalent levels (data not shown). It should
be noted that the level of TraI expression in these experiments
was significantly higher than expression from the single copy of
traI present on pOX38T because of the presence of the multi-
copy expression plasmid pET11d-traI. The higher level of ex-
pression of TraI did not have a negative impact on the comple-
mentation assays.
To confirm that TraI-K998M was active in vivo, the ability of
the protein to function as a transesterase in the donor strain
was assessed by directly measuring the fraction of relaxed F
oriT-containing plasmid molecules in DB11 containing
pET11d-traIK998M. For this purpose a small plasmid, pACY-
CoriT, containing the F oriT was transformed into DB11 har-
boring either pET11d-traI or pET11d-traIK998M. Conversion
of supercoiled pACYCoriT to nicked, open circular pACYCoriT
was analyzed on agarose gels and quantified (Fig. 5). The two
alleles of traI were qualitatively comparable in their ability to
nick pACYCoriT in vivo. It should be noted that conversion of
100% of the plasmid to a nicked form is not expected, even in
the presence of high concentrations of TraI, because the nicked
form of the plasmid is in equilibrium with the supercoiled form
of the plasmid because of the reversible nature of the transes-
terification reaction catalyzed by TraI. Thus, TraI-K998M re-
tains its ability to catalyze the transesterase reaction required
to initiate strand transfer but fails to fulfill all the roles re-
quired of TraI in DNA transfer by virtue of its lack of helicase
activity.
DISCUSSION
The experiments described above address the functional im-
portance of the TraI helicase activity in the DNA transfer
reaction associated with F plasmid-directed bacterial conjuga-
tion. Previous studies have shown that TraI catalyzes two
distinct biochemical reactions, an F plasmid oriT-specific
transesterase reaction and a 59 to 39 helicase reaction (15–20).
The transesterase domain is located at the N-terminal end of
the protein, and the helicase domain encompasses the remain-
der of the protein.2 Because DNA strand transfer begins at the
site- and strand-specific nick introduced within oriT, it is clear
that the transesterase activity of TraI is essential for bacterial
conjugation. However, the role of the helicase activity had not
been directly tested. Indeed, most CDT initiator proteins do not
manifest an intrinsic helicase activity (for review see Ref. 24).
Therefore, it was of interest to determine whether the helicase
activity associated with TraI was essential for CDT.
We have shown, using a deletion mutant lacking the C-
terminal end of TraI and a point mutant that abolished the
helicase activity of TraI, that the helicase activity of TraI is
essential for CDT. Neither mutant was able to provide the
activity necessary to sponsor DNA transfer or complement a
strain harboring a deletion of the traI gene (Table III). Purifi-
FIG. 3. The helicase activity of TraI and TraI-K998M. The heli-
case activity of TraI (filled circles) and TraI-K998M (open circles) was
measured as described under “Experimental Procedures” using a 92-bp
partial duplex substrate. The data represent the average of three inde-
pendent experiments, and the error bars represent the S.D. about the
mean. The fraction of the substrate unwound was calculated as de-
scribed previously (45).
FIG. 4. The transesterase activity of TraI and TraI-K998M. The
transesterase reaction catalyzed by TraI and TraI-K998M was meas-
ured as described under “Experimental Procedures.” Lane 1, super-
coiled pBSoriT DNA; lanes 2–4, supercoiled pBSoriT DNA and 2-fold
increasing concentrations of purified TraI beginning at 38 nM; lanes
5–7, supercoiled pBSoriT DNA and 2-fold increasing concentrations of
purified TraI-K998M beginning at 44 nM; lane 8, supercoiled pBS DNA
and 112 nM purified TraI; lane 9, supercoiled pBS DNA and 123 nM
purified TraI-K998M; lane 10, supercoiled pBS DNA and no protein.
The 0.8% agarose gel was stained with EtBr (0.5 mg/ml).
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cation and biochemical characterization of the proteins ex-
pressed in each case (TraIN956 andTraI-K998M) revealed that
both proteins lacked helicase activity while retaining site- and
strand-specific transesterase activity. Therefore, it was un-
likely that the transesterification reaction was compromised in
vivo. To ensure that this was the case, the ability of TraI-
K998M to nick an F-oriT containing plasmid in vivo was dem-
onstrated (Fig. 5). The fraction of the F oriT-containing plasmid
that was nicked in vivo was essentially equivalent in the strain
harboring the expression plasmid with wild-type traI and the
strain containing the TraI-K998M point mutant. Because the
plasmid is nicked but cannot be transferred, we conclude that
the oriT-specific transesterase activity of TraI is not, by itself,
sufficient to support DNA transfer. The helicase activity is also
essential and is likely providing the force required to drive
strand transfer from the donor to the recipient acting as a
molecular motor. Thus, both activities associated with TraI are
essential for its biological function in CDT.
A previous study (12) reached a different conclusion regard-
ing the role of the helicase activity associated with TraI. These
investigators suggested that deletion of the C-terminal end of
TraI severely affected but did not abolish DNA transfer. This
was interpreted as evidence for partial complementation by a
host-encoded helicase. We were unable to detect any DNA
transfer with the pOX38TtraIDC deletion mutant used in this
study. Assay conditions were varied considerably by titrating
donor to recipient ratios, increasing the time allowed for mat-
ing and altering medium conditions (data not shown). Under no
condition did we observe partial complementation of DNA
transfer as measured in a mating assay. In addition, expression
of the transesterase domain of the protein (TraIN956) in a
strain lacking the traI gene failed to produce any partial
complementation of DNA transfer (Table III). In this case the
transesterase was overexpressed, and a significant fraction of
the transmissible plasmid should have been nicked and com-
petent for transfer. If strand transfer complemented by a host
helicase were to occur as a low frequency event, it should have
been detectable under these conditions. However, this was not
the case, indicating that partial complementation by a host
helicase does not occur. The reason for the discrepancy between
the results reported here and previous results (12) is not clear.
One possibility is the incorrect assignment of various deletions
with specific polypeptides in the previous study, which was
conducted prior to the complete mapping and sequencing of the
distal end of the tra operon. It is now known that the transes-
terase active site is near the N-terminal end of TraI and a
significant portion of the TraI sequence is required to produce
an active helicase.2 In contrast to the previous study, the mu-
tants used here have been characterized at the nucleotide level.
In the previous study it is likely that some low level of residual
helicase activity was present in the complementation con-
structs that were active in DNA transfer. It should be noted
that the helicase-associated motifs do not extend to the extreme
C-terminal end of the traI gene. Therefore, it may be possible to
delete a portion of the C-terminal end of the gene without
compromising helicase activity.
The results presented here demonstrate that nicking at oriT,
although necessary, is not sufficient for DNA transfer. The
plasmid must also be unwound, and the helicase activity of
TraI is essential for unwinding and subsequent DNA transfer.
Thus, this bifunctional protein binds oriT, catalyzes a site- and
strand-specific transesterification reaction and then unwinds
the plasmid to produce the ssDNA that will be transferred to
the recipient cell. Because unwinding is essential for CDT,
other transmissible plasmids that lack a helicase associated
with the CDT initiator protein must usurp a plasmid or cellular
helicase for this purpose. The identity of this helicase is un-
known in most cases. Alternatively, a DNA polymerase capable
of strand displacement synthesis could simultaneously produce
the ssDNA to be transferred to the recipient cell and synthesize
the replacement strand on the donor plasmid. The mechanism
used by conjugative plasmids lacking a CDT initiator protein
with helicase activity remains to be discovered.
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